| Entry |
|
|---|
| Name |
Bivalirudin (USAN/INN);
Angiomax (TN)
|
|---|
| Product |
|
|---|
| Formula |
C98H138N24O33
|
|---|
| Exact mass |
2178.9858
|
|---|
| Mol weight |
2180.2853
|
|---|
| Sequence |
FPRPGGGGNG DFEEIPEEYL |
|---|
| Type |
Peptide |
|---|
| Activity |
Anticoagulant;
Antithrombotic
|
|---|
| Remark |
|
|---|
| Comment |
Peptide
Direct thrombin inhibitor
Hirudin derivative
|
|---|
| Target |
|
|---|
| Pathway |
hsa04610 Complement and coagulation cascades
hsa04810 Regulation of actin cytoskeleton
hsa04810 Regulation of actin cytoskeleton | |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AE Direct thrombin inhibitors
B01AE06 Bivalirudin
D03136 Bivalirudin (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases
thrombin [HSA:2147] [KO:K01313]
Bivalirudin [ATC:B01AE06]
D03136 Bivalirudin (USAN/INN)
 |
|---|
| Other DBs |
CAS: 128270-60-0 PubChem: DrugBank: |
|---|
